Want to join the conversation?
$STJ 2Q15 Call: Neuromodulation product sales in the Q215 were $118MM, which included $7MM of unfavorable foreign currency translations. On a constant currency basis, neuromodulation products sales for the Q215 increased 17%. We continue to expect full year 2015 constant currency neuromodulation product sales growth to be in the range of 13% to 15%
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.